B7-H3-CAR
5 abstracts
Abstract
STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors.Org: Seattle Children’s Research Institute, Seattle Childrens Research Institute,
Abstract
Pan-cancer associations of B7-H3 (CD276) transcriptional expression across human malignancies.Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, Caris Life Sciences, Irving, TX, Puerto Rico Medical Research Center, Barbara Ann Karmanos Cancer Institute, Huntsman Cancer Institute (NCI-CCC),
Abstract
ALAN as an omic tool to build gene signatures and to stratify patients.Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, Institute for Health Informatics, Academic Health Center,
Abstract
Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications.Org: Caris Life Sciences, Irving, TX, Barbara Ann Karmanos Cancer Institute, St. John's Cancer Institute, Santa Monica, CA, Brown University - Lifespan Cancer Institute, University of Minnesota Masonic Cancer Center, Minneapolis, MN,
Abstract
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).Org: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Alabama at Birmingham Department of Hematology, Birmingham, AL, University of Alabama-Birmingham,